Evidence map›Paper›PMID 27184401›Full record

ArticleCell stem cell2016

Mule Regulates the Intestinal Stem Cell Niche via the Wnt Pathway and Targets EphB3 for Proteasomal and Lysosomal Degradation.

Carmen Dominguez-Brauer, Zhenyue Hao, Andrew J Elia, Jérôme M Fortin, Robert Nechanitzky, Patrick M Brauer, Yi Sheng, Miyeko D Mana, Iok In Christine Chio, Jillian Haight and 15 more

Open access · greenAbstract read
In one paragraph

Article in Cell stem cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer.Journal of cancer research and clinical oncology · 2024
    Review
  8. Article
  9. Review
  10. The EPH/Ephrin System in Colorectal Cancer.International journal of molecular sciences · 2022
    Review
  11. Lysosomes at the Crossroads of Cell Metabolism, Cell Cycle, and Stemness.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 4 countries.

Carmen Dominguez-BrauerThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Zhenyue HaoThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Andrew J EliaThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Jérôme M FortinThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Robert NechanitzkyThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Patrick M BrauerSunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
Yi ShengDepartment of Biology, York University, Toronto, ON M3J 1P3, Canada.
Miyeko D ManaThe David H. Koch Institute of Integrative Cancer Research at MIT, Department of Biology, Cambridge, MA 02139, USA.
Iok In Christine ChioCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Jillian HaightThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Aaron PollettDepartment of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
Robert CairnsThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Leanne TworzyanskiThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Satoshi InoueThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Colin ReardonAnatomy, Physiology and Cell Biology, University of California, Davis, Davis, CA 95616, USA.
Ana MarquesThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Jennifer SilvesterThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Maureen A CoxThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Andrew WakehamThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada.
Omer H YilmazThe David H. Koch Institute of Integrative Cancer Research at MIT, Department of Biology, Cambridge, MA 02139, USA.
David M SabatiniThe David H. Koch Institute of Integrative Cancer Research at MIT, Department of Biology, Cambridge, MA 02139, USA; Whitehead Institute for Biomedical Research, Broad Institute, and Howard Hughes Medical Institute, Cambridge, MA 02142, USA.
Johan H van EsHubrecht Institute for Developmental Biology and Stem Cell Research and University Medical Centre Utrecht, Uppsalalaan 8, Utrecht 3584 CT, the Netherlands.
Hans CleversHubrecht Institute for Developmental Biology and Stem Cell Research and University Medical Centre Utrecht, Uppsalalaan 8, Utrecht 3584 CT, the Netherlands.
Toshiro SatoDepartment of Gastroenterology, School of Medicine, Keio University, 35 Shinanomachi, Shinnjukuku, Tokyo 160-8582, Japan.
Tak W MakThe Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2C1, Canada. Electronic address: tmak@uhnresearch.ca.
Ontario Institute for Cancer Research · CAAllen Institute · USHubrecht Institute for Developmental Biology and Stem Cell Research · NLBroad Institute · USCold Spring Harbor Laboratory · USKeio University Hospital · JPMount Sinai Hospital · CASunnybrook Health Science Centre · CAUniversity of California, Davis · USYork University · CA

Funding

Regulation of the mTOR Pathway By NutrientsR01CA103866 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2004 to 2021
$7.0M
Cell Growth Signaling in Cancer DevelopmentR01CA129105 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2008 to 2021
$5.9M
CIHRNCI NIH HHS R01 CA103866NCI NIH HHS R01 CA129105
6 · The paper itself

Abstract

The E3 ubiquitin ligase Mule is often overexpressed in human colorectal cancers, but its role in gut tumorigenesis is unknown. Here, we show in vivo that Mule controls murine intestinal stem and progenitor cell proliferation by modulating Wnt signaling via c-Myc. Mule also regulates protein levels of the receptor tyrosine kinase EphB3 by targeting it for proteasomal and lysosomal degradation. In the intestine, EphB/ephrinB interactions position cells along the crypt-villus axis and compartmentalize incipient colorectal tumors. Our study thus unveils an important new avenue by which Mule acts as an intestinal tumor suppressor by regulation of the intestinal stem cell niche.

Indexed as

ProteolysisStem Cell NicheWnt Signaling PathwayAdenomatous Polyposis ColiAllelesAnimalsCarcinogenesisCell ProliferationColonic NeoplasmsEndocytosisEphrin-B3HEK293 CellsHumansIntestinesLysosomesMice, KnockoutEphrin-B3Huwe1 protein, mouseProteasome Endopeptidase ComplexProto-Oncogene Proteins c-mycTumor Suppressor ProteinsUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID27184401
PMCPMC5193118
OpenAlexW2355672332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.